Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson’s disease

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Neurogenetics

• Publication date

  2006-05-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10048-006-0033-5PMID 16699787
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson’s disease

  2006cited by this paper
• Parkinson's Disease and Brain Mitochondrial Dysfunction: A Functional Phosphorus Magnetic Resonance Spectroscopy Study

  2006cited by this paper
• Lewy bodies.

  2006cited by this paper
• Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration.

  2006cited by this paper
• Microglial activation and dopamine terminal loss in early Parkinson's disease

  2005cited by this paper
• Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis.

  2005cited by this paper
• Harnessing the power of gene microarrays for the study of brain aging and Alzheimer's disease: statistical reliability and functional correlation.

  2005cited by this paper
• Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease

  2005cited by this paper
• Hormones Are Key Actors in Gene X Environment Interactions Programming the Vulnerability to Parkinson's Disease: Glia as a Common Final Pathway

  2005cited by this paper
• Glia cell number modulates sensitivity to MPTP in mice

  2005cited by this paper
• A possible role for humoral immunity in the pathogenesis of Parkinson's disease.

  2005cited by this paper
• Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses

  2004cited by this paper
• Proteasome Inhibition Alters Neural Mitochondrial Homeostasis and Mitochondria Turnover*

  2004cited by this paper
• Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra.

  2004cited by this paper
• Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1

  2004cited by this paper
• p53-mediated mitochondrial dysfunction by proteasome inhibition in dopaminergic SH-SY5Y cells.

  2004cited by this paper
• Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease

  2004cited by this paper
• The mitochondrial RNA polymerase contributes critically to promoter specificity in mammalian cells

  2004cited by this paper
• Parkinson's disease: an update *

  2003cited by this paper
• Altered proteasomal function in sporadic Parkinson's disease.

  2003cited by this paper
• Genes and parkinsonism.

  2003cited by this paper
• Lewy bodies in Betz cells of the motor cortex in a patient with Parkinson's disease

  2003cited by this paper
• Familial Parkinson’s disease: a hint to elucidate the mechanisms of nigral degeneration

  2003cited by this paper
• The Cast of Molecular Characters in Parkinson's Disease

  2003cited by this paper
• Effect of proteasome inhibitor on cultured mesencephalic dopaminergic neurons.

  2003cited by this paper
• Genomics. Microarrays--guilt by association.

  2003cited by this paper
• The role of α-synuclein in Parkinson's disease: insights from animal models

  2003cited by this paper
• The role of alpha-synuclein in Parkinson's disease: insights from animal models.

  2003cited by this paper
• Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease

  2003cited by this paper
• Microarrays--Guilt by Association

  2003cited by this paper
• Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism

  2002cited by this paper
• Synaptic defects in ataxia mice result from a mutation in Usp14, encoding a ubiquitin-specific protease

  2002cited by this paper
• Animal models of Parkinson's disease.

  2002cited by this paper
• Proteasome inhibition causes nigral degeneration with inclusion bodies in rats

  2002cited by this paper
• Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease.

  2002cited by this paper
• Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis.

  2001cited by this paper
• The human genome: gene expression profiling and schizophrenia.

  2001cited by this paper
• Proteasomal inhibition leads to formation of ubiquitin/α‐synuclein‐immunoreactive inclusions in PC12 cells

  2001cited by this paper
• 'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns

  2000cited by this paper
• Chronic systemic pesticide exposure reproduces features of Parkinson's disease

  2000cited by this paper
• Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson’s disease

  2000cited by this paper
• On the Adaptive Control of the False Discovery Rate in Multiple Testing With Independent Statistics

  2000influential reference
• NACP/α-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson’s disease brains

  2000cited by this paper
• NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains.

  2000cited by this paper
• Singular value decomposition for genome-wide expression data processing and modeling.

  2000cited by this paper
• Two novel point mutations of mitochondrial tRNA genes in histologically confirmed Parkinson disease

  1999cited by this paper
• Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

  1998cited by this paper
• The ubiquitin pathway in Parkinson's disease

  1998cited by this paper
• Novel mutations of mitochondrial complex I in pathologically proven Parkinson disease

  1998cited by this paper
• Mitochondrial dysfunction in parkinson's disease

  1998cited by this paper
• Frontotemporal dementia: Neuropil spheroids and presynaptic terminal degeneration

  1998cited by this paper
• Genes and parkinsonism.

  1997cited by this paper
• Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease.

  1994influential reference
• Neuropathology of the substantia nigra.

  1991cited by this paper
• The anatomy and pigmentation of the human substantia nigra in relation to selective neuronal vulnerability.

  1990cited by this paper
• Mitochondrial Complex I Deficiency in Parkinson's Disease

  1989cited by this paper
• Parkinson's disease update.

  1989cited by this paper
• Mitochondrial complex I deficiency in Parkinson's disease.

  1989cited by this paper
• Lewy bodies.

  1986cited by this paper
• The Age of Onset of Parkinson's Disease: Etiological Implications

  1986cited by this paper
• Medicine and the Law

  1983cited by this paper
• Monkey model of Parkinson's disease.

  1983cited by this paper

• Cortical Single-Cell Primers of Abnormal Brain Activity in Parkinson’s Disease

  2025cites this paper
• Initial Molecular Mechanisms of the Pathogenesis of Parkinson’s Disease in a Mouse Neurotoxic Model of the Earliest Preclinical Stage of This Disease

  2024cites this paper
• Combined Metabolic Activators with Different NAD+ Precursors Improve Metabolic Functions in the Animal Models of Neurodegenerative Diseases

  2024cites this paper
• Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrils

  2024cites this paper
• Multi-omics analysis reveals the neuroprotective effect of extract against Parkinson's disease in mouse.

  2024cites this paper
• The latest perspectives of small molecules FMS kinase inhibitors.

  2023cites this paper
• Dynamic Metabolic and Transcriptional Responses of Proteasome-Inhibited Neurons

  2023cites this paper
• Transcriptomic profiling of Parkinson's disease brains reveals disease stage specific gene expression changes

  2023cites this paper
• Voltage-Gated Proton Channel Hv1 Regulates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson’s Disease Models

  2023cites this paper
• Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases.

  2022cites this paper
• Bioengineered models of Parkinson’s disease using patient-derived dopaminergic neurons exhibit distinct biological profiles in a 3D microenvironment

  2022cites this paper
• α-Synuclein at the Presynaptic Axon Terminal as a Double-Edged Sword

  2022cites this paper
• Synucleinopathy-associated pathogenesis in Parkinson’s disease and the potential for brain-derived neurotrophic factor

  2021cites this paper
• Synucleinopathy-associated pathogenesis in Parkinson’s disease and the potential for brain-derived neurotrophic factor

  2021cites this paper
• Combined Metabolic Activators Improve Cognitive Functions without Altering Motor Scores in Parkinson's Disease

  2021cites this paper
• antioxidants

  2020cites this paper
• Mitochondria (cross)talk with proteostatic mechanisms; focusing on ageing and neurodegenerative diseases.

  2020cites this paper
• Effects of L-DOPA on gene expression in the frontal cortex of rats with unilateral lesion of midbrain dopaminergic neurons

  2020cites this paper
• Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration

  2020cites this paper
• Effects of L-DOPA on Gene Expression in the Frontal Cortex of Rats with Unilateral Lesions of Midbrain Dopaminergic Neurons

  2020cites this paper
• Proteasome Subunits Involved in Neurodegenerative Diseases.

  2020cites this paper
• Proteome-Scale Mapping of Perturbed Proteostasis in Living Cells.

  2019cites this paper
• Common gene expression signatures in Parkinson’s disease are driven by changes in cell composition

  2019cites this paper
• Non‐cell‐autonomous actions of &agr;‐synuclein: Implications in glial synucleinopathies

  2018cites this paper
• Transcriptional alterations in skin fibroblasts from Parkinson's disease patients with parkin mutations.

  2018cites this paper
• The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptor

  2018cites this paper
• A review of genome‐wide transcriptomics studies in Parkinson's disease

  2018influential citation
• Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway

  2017cites this paper
• Manganese‐ and 1‐methyl‐4‐phenylpyridinium‐induced neurotoxicity display differences in morphological, electrophysiological and genome‐wide alterations: implications for idiopathic Parkinson's disease

  2017cites this paper
• au NRF 2 Activation Restores Disease Related Metabolic Deficiencies in Olfactory Neurosphere-Derived Cells from Patients with Sporadic Parkinson ' s Disease

  2017cites this paper
• Transcriptional profiling of mRNAs, microRNAs and mitochondrial-nuclear crosstalk in porcine muscle fibers, mitochondrial respiratory and metabolic enzyme activities

  2017cites this paper
• A molecular window into Parkinson’s disease

  2017cites this paper
• MicroRNA-mRNA regulatory networking fine-tunes the porcine muscle fiber type, muscular mitochondrial respiratory and metabolic enzyme activities

  2016cites this paper
• Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases

  2016cites this paper
• Meta-Analysis of Parkinson's Disease Transcriptome Data Using TRAM Software: Whole Substantia Nigra Tissue and Single Dopamine Neuron Differential Gene Expression

  2016cites this paper
• Structure, function and toxicity of alpha‐synuclein: the Bermuda triangle in synucleinopathies

  2016cites this paper
• Discovering transnosological molecular basis of human brain diseases using biclustering analysis of integrated gene expression data

  2015cites this paper
• Intérêt du transcriptome de cellules mononucléées périphériques sanguines dans l’étude des mécanismes moléculaires de la maladie de Parkinson

  2015cites this paper
• AUnifying Hypothesis for Familial and Sporadic Alzheimer ’ s Disease

  2014cites this paper
• A micro-silicon chip for in vivo cerebral imprint in monkey.

  2013cites this paper
• Concise Review: New Paradigms for Down Syndrome Research Using Induced Pluripotent Stem Cells: Tackling Complex Human Genetic Disease

  2013cites this paper
• Current Progress and Future Perspectives: Toward Mitochondrial Medicine

  2013cites this paper
• Decreased parvalbumin mRNA expression in dorsolateral prefrontal cortex in Parkinson's disease

  2013cites this paper
• Gene expression profiling and therapeutic interventions in neurodegenerative diseases: a comprehensive study on

  2012cites this paper
• A Unifying Hypothesis for Familial and Sporadic Alzheimer's Disease

  2012cites this paper
• Systemic and Cell-Type Specific Profiling of Molecular Changes in Parkinson's Disease

  2012cites this paper
• A novel fumarate hydratase-deficient HLRCC kidney cancer cell line, UOK268: a model of the Warburg effect in cancer.

  2012cites this paper
• Gene expression profiling and therapeutic interventions in neurodegenerative diseases: a comprehensive study on potentiality and limits

  2012cites this paper
• Gene expression profiling in human neurodegenerative disease

  2012cites this paper
• Rodent Models and Contemporary Molecular Techniques: Notable Feats yet Incomplete Explanations of Parkinson’s Disease Pathogenesis

  2012cites this paper
• Neurochemistry and the non-motor aspects of PD.

  2012cites this paper
• Up-regulation of metallothionein gene expression in Parkinsonian astrocytes

  2011cites this paper
• Molecular Chaperones and Associated Cellular Clearance Mechanisms against Toxic Protein Conformers in Parkinson’s Disease

  2011cites this paper
• Proteomic analysis of a model fish species exposed to individual pesticides and a binary mixture.

  2011cites this paper
• Decreased expression of B cell related genes in leukocytes of women with Parkinson's disease

  2011cites this paper
• NRF2 Activation Restores Disease Related Metabolic Deficiencies in Olfactory Neurosphere-Derived Cells from Patients with Sporadic Parkinson's Disease

  2011cites this paper
• NRF 2 Activation Restores Disease Related Metabolic Deficiencies in Olfactory Neurosphere-Derived Cells from Patients with Sporadic Parkinson ’ s Disease

  2011cites this paper
• Microarray analysis of differentially regulated genes in human neuronal and epithelial cell lines upon exposure to type A botulinum neurotoxin.

  2011cites this paper
• Expression analysis of dopaminergic neurons in Parkinson’s disease and aging links transcriptional dysregulation of energy metabolism to cell death

  2011cites this paper
• Analysis of Transcriptome Alterations in Parkinson’s Disease

  2011cites this paper
• De la stimulation cérébrale profonde à l’étude physiopathologique de certaines formes génétiques de la Maladie de Parkinson

  2011cites this paper
• Genes regulated in MPTP-treated macaques and human Parkinson's disease suggest a common signature in prefrontal cortex.

  2010cites this paper
• Biomarcadores na doença de Parkinson: avaliação da expressão gênica no sangue periférico de pacientes com e sem mutações nos genes PARK2 e PARK8

  2010cites this paper
• Biomarkers in Parkinson Disease: global gene expression analysis in peripheral blood from patients with and without mutations in PARK2 and PARK8.

  2010cites this paper
• Using ‘omics’ to define pathogenesis and biomarkers of Parkinson’s disease

  2010cites this paper
• Nicotine- and caffeine-mediated changes in gene expression patterns of MPTP-lesioned mouse striatum: Implications in neuroprotection mechanism.

  2010cites this paper
• SRRM2, a Potential Blood Biomarker Revealing High Alternative Splicing in Parkinson's Disease

  2010cites this paper
• Functional genomics analysis of the secretory pathway in Aspergillus niger

  2010cites this paper
• Transcriptome profiling in neurodegenerative disease.

  2010cites this paper
• LRRK2 genetics and expression in the Parkinsonian brain

  2010cites this paper
• Gene expression profiling in progressively MPTP-lesioned macaques reveals molecular pathways associated with sporadic Parkinson's disease.

  2010cites this paper
• Homocysteine-induced endoplasmic reticulum protein (herp) is up-regulated in parkinsonian substantia nigra and present in the core of Lewy bodies.

  2009cites this paper
• Early involvement of the cerebral cortex in Parkinson's disease: convergence of multiple metabolic defects.

  2009cites this paper
• Analysis of Gene Expression in Parkinson's Disease: Possible Involvement of Neurotrophic Support and Axon Guidance in Dopaminergic Cell Death

  2009cites this paper
• Mitochondrial gene profiling: translational perspectives.

  2009cites this paper
• Microglia: biology and pathology

  2009cites this paper
• DnaJB6 is present in the core of Lewy bodies and is highly up‐regulated in parkinsonian astrocytes

  2009cites this paper
• Single‐cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene

  2009cites this paper
• Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology.

  2009influential citation
• Host Response to Botulinum Neurotoxins for Developing Diagnostics and Antidotes

  2009cites this paper
• Target Identification for CNS Diseases by Transcriptional Profiling

  2009cites this paper
• Assessment of the direct and indirect effects of MPP+ and dopamine on the human proteasome: implications for Parkinson’s disease aetiology

  2008cites this paper
• Gene expression profiling in neurological and neuroinflammatory diseases

  2008cites this paper
• Gene Expression Profiles of Mouse Striatum in Control and Maneb + Paraquat-induced Parkinson’s Disease Phenotype: Validation of Differentially Expressed Energy Metabolizing Transcripts

  2008cites this paper
• Towards a pathway definition of Parkinson’s disease: a complex disorder with links to cancer, diabetes and inflammation

  2008cites this paper
• Monoamine oxidase in neuronal cell death

  2008cites this paper
• RNA biomarkers of Parkinson's disease: developing tools for novel therapies.

  2008cites this paper
• The ubiquitin–proteasome system in spongiform degenerative disorders

  2008cites this paper
• The medial and lateral substantia nigra in Parkinson’s disease: mRNA profiles associated with higher brain tissue vulnerability

  2007cites this paper
• Calcium, ageing, and neuronal vulnerability in Parkinson's disease.

  2007cites this paper
• Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: relevance to oxidative damage in Parkinson's disease.

  2007influential citation
• Mitochondrial biogenesis as revealed by mitochondrial transcript profiles during germination and early seedling growth in wheat.

  2007cites this paper
• Neuronal apoptosis mediated by inhibition of intracellular cholesterol transport: Microarray and proteomics analyses in cultured murine cortical neurons

  2007cites this paper
• Analysis of alpha-synuclein, dopamine and parkin pathways in neuropathologically confirmed parkinsonian nigra

  2007cites this paper
• Gene-expression profiling in Parkinson's disease: discovery of valid biomarkers, molecular targets and biochemical pathways

  2007cites this paper
• Neuronal pentraxin II is highly upregulated in Parkinson’s disease and a novel component of Lewy bodies

  2007cites this paper
• Gene and Protein Expression Profiling in Parkinson's Disease: Quest for Neuroprotective Drugs

  2007cites this paper
• Gene and protein signatures in sporadic Parkinson's disease and a novel genetic model of PD.

  2007cites this paper
• Applying transcriptomic and proteomic knowledge to Parkinson's disease drug discovery

  2007influential citation
• Molecular markers of early Parkinson's disease based on gene expression in blood

  2007cites this paper